Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels

Subjects

Abstract

We evaluated the structural/functional characteristics of the arterial wall in a cohort of hypertensives with well-controlled blood pressure (BP) levels. We studied 40 hypertensives with well-controlled BP. We assessed by B-mode ultrasound the mean intima-media thickness (mean-IMT) and maximum-IMT (M-MAX) of carotid artery (common, bulb, internal) bilaterally. Endothelial function was evaluated by post-occlusion flow-mediated dilation (FMD) of the brachial artery. Along with traditional risk factors, we studied the impact of serum high-sensitivity C-reactive protein (hs-CRP) and osteoprotegerin (OPG). Forty normotensive subjects served as controls. In the hypertensives, the BP levels were well controlled (office BP: 129/79 mm Hg, ambulatory BP monitoring: 121/75 mm Hg). Compared with controls, higher BP levels and body mass index were present in hypertensives, whereas age and metabolic parameters were similar. In hypertensives, the IMT (mean-IMT 0.68 mm, M-MAX 0.81 mm) was significantly higher than in controls (mean-IMT 0.60 mm, M-MAX 0.71 mm). FMD was impaired in hypertensives (5.9%) compared with controls (9.2%). In multivariate analyses, it turned out that in hypertensives IMT parameters were related to age, hs-CRP and OPG. Low-density lipoprotein (LDL) cholesterol was the only factor related to FMD. IMT and FMD had no relationship with BP levels. In conclusion, in hypertensives with well-controlled BP, the pro-atherogenic remodelling (IMT) is mainly dependent on age and the inflammatory cytokines, OPG in particular. The functional impairment of the arterial wall (FMD) was related to the levels of LDL cholesterol. Under these conditions, when the impact of BP is minimized, the role of inflammatory cytokines and lipids on structural/functional remodelling becomes predominant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr . Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340 (1): 14–22.

    Article  CAS  Google Scholar 

  2. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE . Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96 (5): 1432–1437.

    Article  CAS  Google Scholar 

  3. Bots ML, Evans GW, Riley WA, Grobbee DE . Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003; 34 (12): 2985–2994.

    Article  Google Scholar 

  4. Pauletto P, Palatini P, Da Ros S, Pagliara V, Santipolo N, Baccillieri S et al. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999; 19 (5): 1231–1237.

    Article  CAS  Google Scholar 

  5. Lemne C, Jogestrand T, de Faire U . Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995; 26 (1): 34–39.

    Article  CAS  Google Scholar 

  6. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004; 18 (4): 346–349.

    Article  Google Scholar 

  7. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23 (1): 7–17.

    Article  CAS  Google Scholar 

  8. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120 (6): 502–509.

    Article  Google Scholar 

  9. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A . Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62 (2): 265–284.

    Article  CAS  Google Scholar 

  10. Ghiadoni L, Faita F, Salvetti M, Cordiano C, Biggi A, Puato M et al. Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens 2012; 30 (7): 1399–1405.

    Article  CAS  Google Scholar 

  11. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41 (6): 1281–1286.

    Article  CAS  Google Scholar 

  12. Hansson GK . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352 (16): 1685–1695.

    Article  CAS  Google Scholar 

  13. Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G . The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. Expert Rev Cardiovasc Ther 2006; 4 (6): 801–811.

    Article  CAS  Google Scholar 

  14. Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S . Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 2012; 125 (22): 2772–2781.

    Article  Google Scholar 

  15. Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 2008; 51 (5): 1300–1305.

    Article  CAS  Google Scholar 

  16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25 (9): 1751–1762.

    Article  CAS  Google Scholar 

  17. Palatini P, Graniero GR, Mormino P, Nicolosi L, Mos L, Visentin P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Circulation 1994; 90 (6): 2870–2876.

    Article  CAS  Google Scholar 

  18. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME . Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb 1993; 13 (1): 90–97.

    Article  CAS  Google Scholar 

  19. Spence JD, Hegele RA . Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24 (11): e188 author reply e–9.

    Article  CAS  Google Scholar 

  20. Mancini GB, Dahlof B, Diez J . Surrogate markers for cardiovascular disease: structural markers. Circulation 2004; 109 (25 Suppl 1): IV22–IV30.

    PubMed  Google Scholar 

  21. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012; 308 (8): 796–803.

    Article  CAS  Google Scholar 

  22. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S . Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009; 157 (4): 527–536.

    Article  CAS  Google Scholar 

  23. Masoura C, Pitsavos C, Aznaouridis K, Skoumas I, Vlachopoulos C, Stefanadis C . Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis 2011; 214 (1): 129–138.

    Article  CAS  Google Scholar 

  24. Vik A, Mathiesen EB, Brox J, Wilsgaard T, Njolstad I, Jorgensen L et al. Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromso Study. J Thromb Haemost 2010; 8 (10): 2133–2139.

    Article  CAS  Google Scholar 

  25. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM . Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340 (8833): 1430–1432.

    Article  CAS  Google Scholar 

  26. Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C et al. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006; 24 (1 Suppl 40): S72–S78.

    CAS  PubMed  Google Scholar 

  27. Zannettino AC, Holding CA, Diamond P, Atkins GJ, Kostakis P, Farrugia A et al. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J Cell Physiol 2005; 204 (2): 714–723.

    Article  CAS  Google Scholar 

  28. Ovchinnikova O, Gylfe A, Bailey L, Nordstrom A, Rudling M, Jung C et al. Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice–brief report. Arterioscler Thromb Vasc Biol 2009; 29 (10): 1478–1480.

    Article  CAS  Google Scholar 

  29. Puato M, Faggin E, Rattazzi M, Paterni M, Kozakova M, Palombo C et al. In vivo noninvasive identification of cell composition of intimal lesions: a combined approach with ultrasonography and immunocytochemistry. J Vasc Surg 2003; 38 (6): 1390–1395.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the Biomedical Foundation for Cardiovascular Research and Gene Therapy of Padova, Italy, (a no-profit Institution) for providing financial support to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Pauletto.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Journal of Human Hypertension website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Puato, M., Rattazzi, M., Zanon, M. et al. Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels. J Hum Hypertens 29, 561–565 (2015). https://doi.org/10.1038/jhh.2014.121

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.121

This article is cited by

Search

Quick links